New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S1744

Introduced
2/28/22  

Caption

Creates registry of individuals who required medical assistance as result of misusing controlled dangerous substance.

Impact

The implementation of S1744 is anticipated to significantly impact state laws surrounding substance misuse and healthcare practices. By centralizing information about individuals who have misused substances, the bill aims to enhance the accountability of healthcare practitioners when prescribing controlled substances. The requirement for practitioners to access this registry may foster a more informed approach to prescription practices, ultimately contributing to the reduction of opioid-related overdoses and encouraging better management of substance abuse cases across New Jersey.

Summary

Senate Bill S1744 aims to create a confidential registry dedicated to individuals who have sought medical assistance due to the misuse of controlled dangerous substances. This registry will be managed by the Commissioner of Human Services and will include names obtained from various emergency medical response entities, hospitals, and police departments. The primary goal of this initiative is to provide healthcare practitioners with access to crucial information before they prescribe any controlled dangerous substances, potentially curbing prescription misuse and addressing issues related to substance abuse, particularly concerning opioids and heroin.

Contention

While the bill has been propagated as a measure to combat substance misuse and safeguard public health, there are notable points of contention. Concerns regarding privacy and the confidentiality of patient information are at the forefront of discussions. Critics argue that, despite its confidential nature, the creation of such a registry might deter individuals from seeking help out of fear of being recorded. Furthermore, the potential misuse of the information collected could lead to stigma against those with substance use disorders, complicating efforts to address these public health challenges.

Companion Bills

No companion bills found.

Previously Filed As

NJ S2451

Creates registry of individuals who required medical assistance as result of misusing controlled dangerous substance.

NJ SB665

Controlled dangerous substances; modifying certain exception to registration requirements. Effective date.

NJ SB665

Controlled dangerous substances; modifying certain exception to registration requirements. Effective date.

NJ HB3567

Controlled dangerous substances; adding to list of Schedule I controlled substances; revocation or suspension of registrations; written orders; repealers; emergency.

NJ A5488

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

NJ SB888

Controlled dangerous substances; providing for registration and regulation of pain management clinics; prohibiting dispensation of controlled dangers substances at pain management clinics. Effective date.

NJ HB3073

Controlled dangerous substances; adding exception to opioid prescription requirements.

NJ SB1897

Controlled dangerous substances; requiring registration of pain management clinics; stating requirements for clinics; providing penalties. Effective date.

NJ HB2584

Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; Committee; members; requirements; Public Health Code; authority for physician assistants to carry out certain functions; prescribing and administering controlled substances; supervision.

NJ HB3965

Physician assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; committee; members; requirements; practice agreements; prescribing; emergency.

Similar Bills

NJ S2451

Creates registry of individuals who required medical assistance as result of misusing controlled dangerous substance.

NY A08484

Directs the commissioner of veterans' services to establish a registry of self-identifying service members, veterans and family members of such individuals who may have experienced exposure to a hazardous substance at a military installation and to establish and maintain a public information program in order to educate and inform service members, veterans, and their families.

VT S0197

An act relating to restricting perfluoroalkyl and polyfluoroalkyl substances in consumer products

NJ S1068

"Mental Health Access Act;" increases Medicaid reimbursement rates for certain evidence-based behavioral health services.

NJ A555

"Mental Health Access Act;" increases Medicaid reimbursement rates for certain evidence-based behavioral health services.

NJ A2764

"Mental Health Access Act;" increases Medicaid reimbursement rates for certain evidence-based behavioral health services.

NJ S4015

Clarifies DHS authority to regulate sober living homes and halfway houses as residential substance abuse aftercare facilities; requires background checks and other protections for residents of residential substance abuse facilities.

MN SF73

Cannabis provisions modification